TNF Pharmaceuticals (TNFA) Competitors $1.31 -0.02 (-1.50%) (As of 11/4/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsSEC FilingsTrends TNFA vs. TRIB, AWH, VRAX, CDIO, BMRA, MYMD, NAVB, IDXX, LNTH, and NEOGShould you be buying TNF Pharmaceuticals stock or one of its competitors? The main competitors of TNF Pharmaceuticals include Trinity Biotech (TRIB), Aspira Women's Health (AWH), Virax Biolabs Group (VRAX), Cardio Diagnostics (CDIO), Biomerica (BMRA), MyMD Pharmaceuticals (MYMD), Navidea Biopharmaceuticals (NAVB), IDEXX Laboratories (IDXX), Lantheus (LNTH), and Neogen (NEOG). These companies are all part of the "diagnostic substances" industry. TNF Pharmaceuticals vs. Trinity Biotech Aspira Women's Health Virax Biolabs Group Cardio Diagnostics Biomerica MyMD Pharmaceuticals Navidea Biopharmaceuticals IDEXX Laboratories Lantheus Neogen TNF Pharmaceuticals (NASDAQ:TNFA) and Trinity Biotech (NASDAQ:TRIB) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, profitability, risk, community ranking, valuation, earnings, analyst recommendations and media sentiment. Do insiders & institutionals have more ownership in TNFA or TRIB? 9.6% of TNF Pharmaceuticals shares are held by institutional investors. Comparatively, 79.0% of Trinity Biotech shares are held by institutional investors. 2.1% of TNF Pharmaceuticals shares are held by insiders. Comparatively, 8.2% of Trinity Biotech shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Do analysts prefer TNFA or TRIB? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TNF Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ATrinity Biotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Is TNFA or TRIB more profitable? TNF Pharmaceuticals has a net margin of 0.00% compared to Trinity Biotech's net margin of -38.02%. Trinity Biotech's return on equity of 0.00% beat TNF Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets TNF PharmaceuticalsN/A -205.91% -95.41% Trinity Biotech -38.02%N/A -26.62% Does the media favor TNFA or TRIB? In the previous week, TNF Pharmaceuticals' average media sentiment score of 0.00 equaled Trinity Biotech'saverage media sentiment score. Company Overall Sentiment TNF Pharmaceuticals Neutral Trinity Biotech Neutral Which has preferable earnings and valuation, TNFA or TRIB? TNF Pharmaceuticals has higher earnings, but lower revenue than Trinity Biotech. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTNF PharmaceuticalsN/AN/A-$4MN/AN/ATrinity Biotech$58.65M0.22-$24.02M-$2.70-0.63 Does the MarketBeat Community favor TNFA or TRIB? Trinity Biotech received 335 more outperform votes than TNF Pharmaceuticals when rated by MarketBeat users. CompanyUnderperformOutperformTNF PharmaceuticalsN/AN/ATrinity BiotechOutperform Votes33572.04% Underperform Votes13027.96% Which has more volatility & risk, TNFA or TRIB? TNF Pharmaceuticals has a beta of 2.17, meaning that its share price is 117% more volatile than the S&P 500. Comparatively, Trinity Biotech has a beta of 1.13, meaning that its share price is 13% more volatile than the S&P 500. SummaryTrinity Biotech beats TNF Pharmaceuticals on 6 of the 9 factors compared between the two stocks. Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Get TNF Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNFA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TNFA vs. The Competition Export to ExcelMetricTNF PharmaceuticalsDiagnostic substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.11M$2.55B$5.04B$8.43BDividend YieldN/A0.70%7.52%4.16%P/E RatioN/A5.89130.2316.67Price / SalesN/A30.341,720.2276.26Price / CashN/A15.5136.9133.54Price / Book0.183.064.604.98Net Income-$4M$29.98M$114.94M$224.26M7 Day Performance-25.57%-6.55%0.14%1.65%1 Month Performance-15.48%-1.02%10.15%6.92%1 Year PerformanceN/A-4.95%33.87%26.46% TNF Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TNFATNF PharmaceuticalsN/A$1.31-1.5%N/AN/A$3.11MN/A0.006Gap UpTRIBTrinity Biotech0.4635 of 5 stars$2.16-2.0%N/A-26.4%$16.42M$56.83M-0.80480Gap DownAWHAspira Women's Health1.1719 of 5 stars$0.95+1.6%$4.40+360.9%-80.9%$15.33M$9.15M-0.66110Upcoming EarningsAnalyst ForecastGap DownVRAXVirax Biolabs Group0.4083 of 5 stars$2.17-1.8%N/A-19.7%$7.01M$160,000.000.005Gap UpCDIOCardio Diagnostics3.0907 of 5 stars$0.25-20.1%$2.00+702.9%-30.6%$5.65M$39,138.000.007Upcoming EarningsGap DownBMRABiomerica0.9044 of 5 stars$0.32+2.3%N/A-56.7%$5.39M$5.51M-0.8960Positive NewsGap DownMYMDMyMD PharmaceuticalsN/A$1.76+4.8%N/A-88.6%$4.17MN/A0.009Gap UpNAVBNavidea BiopharmaceuticalsN/A$0.00flatN/AN/A$100,000.00$8,126.00-0.0210IDXXIDEXX Laboratories4.7979 of 5 stars$447.71-0.4%$574.13+28.2%-2.8%$36.98B$3.78B44.3311,000Earnings ReportAnalyst ForecastLNTHLantheus3.8992 of 5 stars$106.38-3.4%$126.00+18.4%+67.9%$7.37B$1.44B17.44834Upcoming EarningsNews CoverageNEOGNeogen2.4819 of 5 stars$14.08+0.2%$17.50+24.3%-8.7%$3.05B$924.22M-128.002,640Positive News Related Companies and Tools Related Companies Trinity Biotech Alternatives Aspira Women's Health Alternatives Virax Biolabs Group Alternatives Cardio Diagnostics Alternatives Biomerica Alternatives MyMD Pharmaceuticals Alternatives Navidea Biopharmaceuticals Alternatives IDEXX Laboratories Alternatives Lantheus Alternatives Neogen Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TNFA) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TNF Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TNF Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
